Sched.com Conference Mobile Apps
DIA 2025 Global Annual Meeting
DIA 2025 Global Annual Meeting
Sign up
or
log in
to add sessions to your schedule and sync them to your phone or calendar.
Schedule
Speakers
Search
Menu
Schedule
Speakers
Search
Emily Gebbia
FDA, United States
Associate Director for Regulatory Development, OSI, OC, CDER
Patrick Gee
iAdvocate, United States
Chief Executive Hope Dealer & Founder
Victoria Gemme
National Organization for Rare Disorders, United States
Director, Policy and Regulatory Affairs
Lincy George
Sanofi, United States
Vice President, Oncology Global Regulatory Affairs
Ellyn Getz
CSL Behring, United States
Director, R&D Partnerships
Kenneth Getz
Tufts University School of Medicine, United States
Tufts Center for the Study of Drug Development
Alicia Gilsenan
RTI Health Solutions, United States
Vice President, Epidemiology
Richard Gliklich
OM1, United States
Founder & Chief Executive Officer
Sarah Golding
Therapeutics Goods Administration, Australia
Senior Medical Officer - Oncology and Malignant Haematology Clinical...
Katharina Goldner
Bayer AG, Germany
Regional Regulatory Affairs Manager
Gretchen Goller
Pfizer, United States
Head, Recruitment and Retention
Julien Nunes Goncalves
Cyntegrity, South Africa
Head of Growth
MP
Mercedes Perez Gonzalez
WHO, Switzerland
Technical officer
Robert (Mac) Gordon
Johnson & Johnosn Innovative Medicines, United States
Director, Biostatistics
RG
Ryan Gough
Woodberry Associates and PACH, United States
Partner, Senior Vice President, Public Affairs
Heidi Grabenstatter
Critical Path Institute, United States
Scientific Director, RDCA-DAP
Cheryl Grandinetti
FDA, United States
Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
Courtney Granville
GO2 For Lung Cancer, United States
Chief Scientific Officer
Hannah Graunke
Duke-Margolis Institute For Health Policy, United States
Senior Policy Analyst
Dionna Green
FDA, United States
Director, Office of Pediatric Therapeutics
Catherine Gregor
Florence Healthcare, United States
Chief Clinical Trial Officer
Susan Gregurick
National Institute of Health, United States
Associate Director, Data Science and Director, NIH ODSS
Vinita Grover
Microsoft, United States
Anthony Gulotta
Leal Health, United States
Head of Sales and Strategic Partnerships
Tanvi Gupte
University of Maryland, United States
Student
Michelle Gyzen
IQVIA, United States
Senior Director, Regulatory Innovation & Technology
Ann Marie Hake
Eli Lilly and Company, United States
Executive Director, Medical – Digital Health
Hilmar Hamann
European Medicines Agency, Netherlands
Head of Information Management
Tarek Hammad
Takeda, United States
Vice President, Head of Medical Safety, Marketed Products &...
Gerrit Hamre
Duke-Margolis Institute For Health Policy (DMI), United States
Research Director
Jackson Hanf
University of Southern California, United States
Student
Morgan Hanger
Clinical Trials Transformation Initiative (CTTI), United States
Executive Director
Magdalena Harrington
Pfizer, United States
Senior Director, Patient-Centered Outcomes Assessment (PCOA) Team Lead
Meghann Hartnett
DIA, United States
Associate Director, Global Products
Fadhilah Hasbullah
National Pharmaceutical Regulatory Agency (NPRA) Malaysia, Malaysia
GCP Inspector
Sema Hashemi
FDA, United States
Senior International Policy Advisor
Lani Hashimoto
Hashimoto Consulting Services, United States
Consultant, Patient Experience
Kristin Hatcher
Global Liver Institute/Alpha One Patient, United States
Director of Pediatric and Rare Disease/ Alpha One Lived Experience...
Brett Hauber
Pfizer Inc, United States
Patient Preference Evidence Integration Lead
RH
Reina Hayashi
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office of Non-clinical and Clinical Compliance
Melissa Heidelberg
Takeda, United States
Director, Global Bioethics and Technology Ethics Lead
Rachele Hendricks-Sturrup
Duke-Robert J. Margolis, MD, Institute For Health Policy, United States
Research Director, Real-World Evidence
Nicole Herk
Medtronic, United States
Analytics Director
MP
Melissa Pauline Herman
Lundbeck A/S, Denmark
Senior Specialist, Patient Insights
Adrian Hernandez
Duke Clinical Research Institute , United States
Professor of Medicine; Executive Director
Ralf Herold
European Medicines Agency, Netherlands
Head of Regulatory Science and Academia Workstream
Christopher Herrick
Mass General Brigham (MGB), United States
VP of Research Systems and Technology
LH
Leanne Hickman
Eli Lilly and Company, United States
Senior Vice President, Global Quality Analytical Sciences & QC...
Amber Hill
R.grid, United Kingdom
Founder & CEO
Amber Hill
R.grid, United Kingdom
Founder & CEO
Hideki Hiraoka
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer
MH
Michal Hirsh-Vexberg
Israel Ministry of Health, Israel
Head of the Pharmaceuticals Registration Department, Medical...
Peter Hjelmstrom
Uppsala Monitoring Centre, Sweden
Director/CEO
Kowid Ho
F. Hoffmann-La Roche Ltd, Switzerland
Pharma Technical Regulatory Policy
Martin Hodosi
Kearney, United Kingdom
Partner, Healthcare and Life Sciences Practices
Eimy Honda
University of São Paulo, MBA USP/Esalq, Brazil
Pharmacovigilance Specialist
Paula Horowitz
AbbVie, United States
Program Manager, QA, GCP Software Validation
Ryan Hoshi
AbbVie, United States
Director, Regulatory Policy and Intelligence
PH
Philip Hougaard
Lundbeck A/S, Denmark
Vice President, Biostatistics and Data Science
Brett Howard
USP, United States
Senior Director, US Regulatory Policy
Endang Hoyaranda
Indonesian Association For the Study of Medicinals (IASMED), Indonesia
President
Alice Hsu
Amgen Inc., United States
Director Integrated Signal Management
Angela Hu
Parexel, United States
VP, Biostatistics
Li Huang
Phastar, United States
Principal Biostatistician
Sheilyn Huang
FDA, United States
Consumer Safety Officer, Pharmacovigilance Compliance Team
Tse-Yin Huang
Center for Drug Evaluation, Taiwan, Taiwan
Reviewer
Wei-I Huang
Taiwan Drug Relief Foundation, Taiwan
Director, Division of Drug Safety
Lisa Hubbard
Opus Regulatory, Inc., United States
Principal Consultant, Regulatory Advertising and Promotion
Melissa Hunt
Health Canada, Canada
Director
BH
Brian Hunter
CNS Healthcare / Sitecentric, United States
VP / Chief Operating Officer
BH
Brian Hunter
SiteCentric, United States
Chief Operating Officer
Robert Huntington
ROTHWELL, FIGG, ERNST & MANBECK, P.C. , United States
Lawyer
Stacy Hurt, MBA, MHA
Parexel, United States
Chief Patient Officer
Campbell Hutton
Breakthrough T1D, United States
Senior Vice President, Global Advocacy
Huong Huynh
Critical Path Institute, United States
Director of Regulatory Science
TH
Tran Huynh
Fortrea, United States
Director, Clinical Vendor Strategy
Anna Hyde
Arthritis Foundation, United States
Vice President of Advocacy & Access
Edward Ian
Mediscience Planning Inc., Japan
Head of Integrated Innovation Service Center
Ana-Claudia Ianos
Pfizer Inc, United States
Senior Director, Safety Risk Management Lead
SI
Sameera Ibrahim
Bristol Myers Squibb, United Kingdom
Head of Risk Governance & Operations, R&D Quality
KI
Kentaro Ichinose
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Inspector
Taruna Ikrar
Indonesia Food and Drug Authority, Indonesia
Chairperson
William Illis
Novartis , United States
Global Head, Collaboration/Technology Strategy, Clinical Development...
Anne Marie Inglis
GSK, United States
Senior Director, Clinical Operations Asset Lead
Elizabeth Iorns
CEO and Co-Founder, United States
Science Exchange
MI
Maxwell Isaacoff
Elevance Health, Inc, United States
Director, Federal & External Affairs
Akihiro Ishiguro
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Head of PMDA, Washington D.C. Office
Md Rashedul Islam
Queensborough Community College, United States
Student, Undergraduate Research Scholar
David Isom
Pfizer Inc, United States
Senior Director, Global Regulatory Policy and Intelligence, Global...
Aarthi Iyer
Cogent Biosciences, Inc., United States
Senior Corporate Counsel
CJ
Charles Jaffe
HL7, United States
Chief Executive Officer
Nabeela Jahangeer
University of Southern California, United States
Student
RJ
Ritesh Jain
EMD Serono, United States
Senior Director
Sid Jain
Recursion, United States
Senior Vice President, Clinical Development and Data Science
Linda Jeng
FDA, United States
Associate Director for Biomedical Informatics
Sheila Mahoney Jewels
LifeSciHub , United States
Drug Development Multi-Functionalist
Xiangxiang Jiang
University of South Carolina, United States
PhD student
Tony Johnson
Mallinckrodt Pharmaceuticals, United States
Senior Director, Clinical Quality
Jeremy Jokinen
Bristol-Myers Squibb Company, United States
Vice President and Head, Safety Evidence and Sciences
Brad Jordan
Eli Lilly and Company, United States
Associate Vice President, Regulatory Policy and Strategy
KW
Kenneth Wiley. Jr.
National Center For Advancing Translational Sciences, United States
Section Chief
Tom Julian
Gilead Sciences, United States
Assoc. Director Design and Innovation
Zhanna Jumadilova
Pfizer Inc, United States
Clinical Lead
Patricia Jumelle
University of Southern California, United States
Student
HYUN JOO JUNG
Korea Institute of Drug Safety & Risk Management, Korea, Republic of
Departiment of Drug Safty Information
Tae Hyun Jung
FDA, United States
Senior Statistical Reviewer, CDER
EJ
Elizabeth Jungman
United States
Former FDA Chief of Staff
Andrea Jux
Genmab US, Inc., United States
Senior Director, Development Program Management
MIDHUN RAJ K
IQVIA, India
Manager, Signal Management
Rasika Kalamegham
Genentech, A Member of the Roche Group, United States
Head, US Regulatory Policy
Linda Kalilani
GlaxoSmithKline, United States
Senior Director and Head of Oncology Epidemiology
Lisa Kammerman
Kammerman Consulting, LLC, United States
Regulatory Statistics and PRO Consultant
Joseph Kannarkat
Johns Hopkins University School of Medicine, United States
Physician
Chris Karlovich
Frederick National Laboratory for Cancer Research, United States
Director, Molecular Characterization Laboratory
Stephen Karpen
Breakthrough T1D, United States
Senior Director, Regulatory Affairs
Elaine Katrivanos
Tempus AI, United States
Vice President Regulatory Affairs
Terry Katz
Daiichi Sankyo, United States
Senior Director, Biostatistics and DM Planning and Functional...
Melody Keel
The Research Associate Group, Inc., United States
Founder, CEO and Consultant
Lindsay Kehoe
Clinical Trials Transformation Initiative (CTTI), United States
Senior Project Manager, Lead Emerging Programs
Annie Kennedy
EveryLife Foundation for Rare Diseases, United States
Chief of Policy, Advocacy, and Patient Engagement
Jo Kerwin
Jo Ann Kerwin, United States
Senior Director Strategic Planning &. Operations
Una Kessi
Oracle Health & Life Sciences, United Kingdom
Product Management Director, Safety and Pharmacovigilance
Madiha Khalid
Larimar Therapeutics, United States
Senior Director, Medical Writing
Irfan Khan
Circuit Clinical, United States
Founder and Chief Executive Officer
Warren Kibbe
National Cancer Institute, United States
Deputy Director, Data Science and Strategy
Emma Kikerkov
Eshelman School of Pharmacy, United States
Pharmacy and MPH Student
Bonggi Kim
Korea Institute of Drug Safety and Risk Management, Korea, Republic of
Director
Jennifer Kim
Tufts Center for the Study of Drug Development, United States
Research Associate Professor
Yoon Jeon (Jamey) Kim
Merck & Co., Inc., Rahway, NJ, USA, Panama
Director, Cluster Pharmacovigilance Lead
Sabina Kineen
Rare Disease Patient Advocacy, United States
Lived Experience Expert
Ray Kirchmier
Deloitte, United States
Manager
Yasuhiro Kishioka
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of Cellular and Tissue-based Products
Teppei KIUCHI
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Jesper Kjaer
Novo Nordisk, Denmark
Global Director for Public, Private Partnerships, Strat Ops, Global...
MK
Matthew Klein
PTC Theraputics, United States
CEO
Holly Kleinschrodt
Astellas, United States
Head, Device & Operations Quality
Timothy Kline
GSK, United States
Senior Director, Global Regulatory Affairs
Nobutaka Kobayashi
Mitsubishi Tanabe Pharma Corporation, Japan
Deputy Director
Toshitatsu Kobayashi
Otsuka Pharmaceutical Co., Ltd., Japan
Senior Regulatory Expert
Marina Kobiashvili
Independent Consultant, United States
AK
Armin Koch
Hannover Medical School, Germany
Head, Institute of Biometry
Chaitanya Koduri
US Pharmacopeia, United States
Director, International Government and Regulatory Engagement
Daisuke Koga
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Director, Office of International Strategy and Planning
Isaac Kohane
Harvard Medical School, United States
Chair, Department of Biomedical Informatics
Daisuke Koide
Graduate School of Medicine, The University of Tokyo, Japan
Project Professor, Department of Biostatistics and Bioinformatics
Evdokia Korakianiti
European Medicines Agency, Netherlands
Head of Quality and Safety of Medicines
Hema Kothari
Bristol Myers Squibb, United States
Scientific Writer II
Namita Kothary
FDA, United States
Associate Director, DEPS, OSI, OC, CDER
Sandra Krogulski
Bristol Myers Squibb, United States
Director, GRSO Innovation and Business Operations Lead
Andrea Kurz
F. Hoffmann-La Roche Ltd, Switzerland
Senior Director, Lead External Advocacy Europe & Middle East
Dominique Lagrave
Accumulus Synergy, United States
Senior Vice President of Regulatory Innovation
Melissa Laitner
National Academy of Medicine, United States
Director, Strategic Initiatives
Mary Jo Lamberti
Tufts Center for the Study of Drug Development, United States
Director of Sponsored Research, Research Associate Professor
Celeste Frankenfeld Lamm
Merck Sharp & Dohme LLC , United States
Senior Director, Global Regulatory Affairs – CMC
Jeff Lange
Amgen, Hong Kong
Director of Observational Research in Asia
Robyn Langham
Australia Health Products Regulation Group, Australia
Chief Medical Adviser
LL
Laura Lasiter
Astrazeneca, United States
Regulatory Affairs Director- Digital Health
Marion Laumonier
World Health Organization (WHO), Switzerland
Technical Officer, Regulatory Convergence and Networks
Tony Lawler
Australian Department of Health and Aged Care, Australia
Deputy Secretary, Health Products Regulation Group
Agathe Le Lay
H. Lundbeck A/S, Denmark
Global Head of Value Evidence & Patient Insights
Lauren Le
Butler University, United States
Student
Charles Lee
AstraZeneca, United States
Executive Regulatory Science Director
IL
Iyn-Hyang Lee
College of Pharmacy, Yeungnam University, Korea, Republic of
Professor
Jeremiah Lee
University of Southern California, United States
Research Ambassador
Kerry Jo Lee
FDA, United States
Assoc. Dir. for Rare Diseases; Program Manager, Accelerating Rare...
Kevin Lee
Clinvia, United States
Data Scientist
Sue Lee
Takeda, United States
Director, Global Patient Safety Signal Management and Innovation
DL
Dianliang Lei
World Health Organization (WHO), Switzerland
Scientist of Technology, Standard and Norm
Patty Leuchten
Diligent Pharma, United States
Founder and CEO
PL
Patrick Leung
Faro Health Inc. , United States
Chief Technology Officer
Bennett Levitan
Johnson & Johnson, United States
Executive Director, Benefit-Risk Assessment / Epidemiology
JL
Jie Li
FDA, United States
Associate Director for RWE, OSE, CDER
Ye Li
FDA, United States
Mathematical Statistician, OTS, CDER
Dun Liang
Eli Lilly & Co., United States
Director, Global Regulatory Affairs, Diagnostics
FL
Franca Ligas
European Medicines Agency, Netherlands
Scientific Officer, Paediatric Medicines Office
ML
Marie Liles-Burden
Takeda, United States
Director, Pharmacovigilance Risk Management
Min-Jung Lim
MediSafe, Pharmacovigilance Services, Korea, Republic of
CEO & Senior Pharmacovigilance Consultant
Anran Liu
U.S. Food and Drug Administration, United States
ORISE Postdoctoral Fellow
Hangyu (cedric) Liu
Biogen, United States
Associate Director, AI/ML
John Lockwood
Cencora Pharmalex, United States
Sr. Director
PL
Patrick Loerch
Gilead Sciences, Inc., United States
Senior Vice President, Clinical Data Science
Katherine Van Loon
UCSF Helen Diller Family Comprehensive Cancer Center, United States
Director, Global Cancer Program
James Lovett
Myonex, United States
CEO
Kevin Lu
Taimei Technology, United States
CTO
Jingyu (Julia) Luan
AstraZeneca, United States
Executive Regulatory Science Director, BioPharmaceuticals R&D
Tyler Ludlow
Decision Skills Institute, United States
Founder and Chief Decision Scientist
NM
Nell Meosky Luo
Folia Health, United States
Chief Executive Officer
Sarah Lyons
IQVIA, Canada
Head of Operations, Applied AI Science
BM
Bei Ma
The Pinea Group, LLC, United States
Founder and CEO
BM
Bo Maach-Møller
Novo Nordisk A/S, Denmark
Vice President, Risk Based Quality Management
Tara MacCannell
Vertex Pharmaceuticals, United States
Global Head and Executive Director, RWE
Demetra Macheras
AbbVie, United States
Director, Regulatory Policy and Intelligence - Regulatory Affairs
Christina Mack
IQVIA, United States
Chief Scientific Officer, Real-World Solutions
Subha Madhavan
Pfizer Inc, United States
Vice President and Head of AI/ML, Global Biometrics and Data...
Nicole Mahoney
Novartis, United States
Executive Director US Regulatory Policy & Intelligence
Stephen Mahoney
Gilead Sciences, United States
Head of Quality Policy and Advocacy
Madhurima Majumder
Bayer US LLC, United States
Associate Director, Clinical Statistics and Analytics
Tariro Makadzange
Zimbabwe Clinical Research Center, United States
Executive Director, Founder
Martin Makary
FDA, United States
Commissioner
Ritika Malik
Temple University, United States
Student
1
2
3
4
Share Modal
Share this link via
Or copy link
Copy
